Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VinMetAtezo: Vinorelbine and Atezolizumab in Second-line Stage IV NSCLC
NCT03801304Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of atezolizumab, vinorelbine in non-small cell lung cancer (NSCLC), sponsored by Centre Hospitalier Universitaire de Brest. Started Jan 2019; status: completed.
02
Drugs
atezolizumabvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03801304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801304.